Tirzepatide is a novel medication that acts as a dual agonist for the GLP-1 and GIP receptors
Under the right medical supervision, the benefits can be life saving
These improvements often offset concerns about moderate lean mass changes, especially when combined with the metabolic benefits of improved body composition ratios
Do not start, stop, or change any prescription medication without speaking with your prescriber
Repeated reactions at the same site If one particular injection area (say, the left lower abdomen) consistently produces worse reactions than other areas, stop using that site
For a 2.5mg (2,500mcg) dose: 2,500 / 5,000 x 100 = 50 units